-
-
-
-
-
-
-
BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for Merger
-
-
-
-
-
-
-
Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Eidos Therapeutics (EIDX) After BBIO Reconsiders Consolidating its Position
-
-
-
-
-
-
-
Eidos Therapeutics (EIDX) Confirms Receipt of Non-Binding Proposal from BridgeBio Pharma to Acquire Shares
-
-
-
-
-
-
-
Hercules Capital Proudly Announces Eight Portfolio Companies Have Completed or Announced an IPO or M&A Liquidity Event Year-to-Date 2018
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

